AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Feb 16, 2011
30016_dirs_2011-02-16_efec842f-8587-48fc-bcbb-a4f71f2d9038.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-02-14
Reporting Person: TWIGGE GIOVANI (CORPORATE VICE PRESIDENT)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-14 | Non-Qualified Stock Option (right to buy) | $77.59 | A | 7715 | Acquired | 2018-02-13 | Common Stock (7715) | Direct |
| 2011-02-14 | Incentive Stock Option (right to buy) | $77.59 | A | 1288 | Acquired | 2018-02-13 | Common Stock (1288) | Direct |
| 2011-02-14 | Restricted Stock Unit | $ | A | 967 | Acquired | Common Stock (967) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock becomes exercisable as to 1,801 shares on each of 02/14/2012, 02/14/2013 and 02/14/2014, 1,800 shares on 02/14/2015, and the remaining 512 shares on 02/14/2016.
F2: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2016) of the grant.
F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.